Search results
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 4 days agoSupported by robust data from two Phase 3 clinical trials, INSPIRE and COMMAND, the approval highlights Skyrizi’s potential to become a cornerstone therapy in AbbVie’s portfolio, particularly ...
FDA Plans to Ease Requirements for Biosimilars' Interchangeable Status
MedPage Today· 5 days agoThe FDA on Thursday announced that biosimilars seeking an interchangeable status would no longer require studies showing that switching between a biosimilar and its branded reference product ...
US FDA proposes to remove switching study requirement for biosimilars
Reuters via AOL· 4 days agoThe designation allows pharmacists to substitute branded drugs with their close copies easily....
Gateway - Quartz
Quartz· 7 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar drug that dominates a market, brings in hordes of customers, and deposits hefty profits in ...
Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for June 2024
InvestorPlace· 4 days agoAs we move into June, I’ve identified three top retirement stocks that could be excellent long-term...
Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a...
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of the 10 Best Robinhood Stocks Under $20. In this article, we are going...
10 things to watch in the stock market Tuesday including Nvidia price-target hikes
CNBC· 6 days agoMy top 10 things to watch Tuesday, June 18 Markets are poised for a subdued open Tuesday following a...
1,533 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Warren Street Wealth Advisors LLC
ETF DAILY NEWS· 7 days agoWarren Street Wealth Advisors LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ...
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now | The Motley Fool
The Motley Fool· 6 days agoGrowth stocks are the rage on Wall Street lately. Tech standouts like Microsoft, Nvidia, and CrowdStrike are regularly reaching new all-time highs. Microsoft and Nvidia pay token dividends, ...
AbbVie names Roxanne Austin as new lead independent director By Investing.com
Investing.com· 4 days agoAustin will be taking over from Glenn F. Tilton, who will continue his tenure on the board as an...